Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia.
The Sleep Health Foundation, Blacktown, New South Wales, Australia.
J Clin Sleep Med. 2021 Oct 1;17(10):2085-2097. doi: 10.5664/jcsm.9354.
The coronavirus disease 2019 (COVID-19) pandemic has led to an increased prevalence of insomnia and mental health symptoms globally. However, most studies to date have not examined mental health symptoms between individuals with insomnia, either pre-existing or developing post-pandemic compared with good sleepers. This study examined differences in stress, anxiety, and depression between individuals with pre-existing insomnia symptoms, post-pandemic insomnia symptoms, and no insomnia symptoms in response to the COVID-19 pandemic.
A cross-sectional survey was completed by 2724 participants from 67 countries during the COVID-19 pandemic. Perceived stress, anxiety, and depressive symptoms were compared between individuals with post-pandemic insomnia symptoms (n = 1007), pre-existing insomnia symptoms (n = 804), and no insomnia symptoms (n = 913).
Post-pandemic insomnia symptoms were associated with higher levels of stress, anxiety, and depression than pre-existing or no insomnia symptoms ( < .001). Pre-existing insomnia symptoms were also associated with higher levels of stress, anxiety, and depression than no insomnia symptoms ( < .001). Individuals who met likely criteria for acute insomnia also reported higher stress, anxiety, and depression than those with insomnia disorder ( < .001). Across all groups, individuals reporting a previous mental health diagnosis had worse stress, anxiety, and depression than those without a previous mental health diagnosis ( < .001). Last, individuals from South Africa reported higher levels of stress, anxiety, and depression than other countries ( < .01).
Internationally, individuals with pre-existing and post-pandemic insomnia symptoms may be more susceptible to stress, anxiety, and depression during the COVID-19 pandemic. Public health initiatives should include insomnia management to improve mental health during the pandemic.
Meaklim H, Junge MF, Varma P, Finck WA, Jackson ML. Pre-existing and post-pandemic insomnia symptoms are associated with high levels of stress, anxiety, and depression globally during the COVID-19 pandemic. . 2021;17(10):2085-2097.
2019 年冠状病毒病(COVID-19)大流行导致了失眠和全球心理健康症状的普遍增加。然而,迄今为止的大多数研究都没有检查过患有失眠症(无论是先前存在的还是大流行后出现的)的个体与睡眠良好的个体之间的心理健康症状。本研究检查了在 COVID-19 大流行期间,患有先前存在的失眠症状、大流行后出现的失眠症状和无失眠症状的个体之间应激、焦虑和抑郁的差异。
在 COVID-19 大流行期间,来自 67 个国家的 2724 名参与者完成了一项横断面调查。比较了大流行后失眠症状(n=1007)、先前存在的失眠症状(n=804)和无失眠症状(n=913)个体之间的感知压力、焦虑和抑郁症状。
大流行后失眠症状与应激、焦虑和抑郁水平升高有关,高于先前存在或无失眠症状(<0.001)。先前存在的失眠症状也与应激、焦虑和抑郁水平升高有关,高于无失眠症状(<0.001)。符合急性失眠可能标准的个体报告的应激、焦虑和抑郁水平也高于失眠障碍患者(<0.001)。在所有组中,有先前精神健康诊断的个体的应激、焦虑和抑郁水平均高于无先前精神健康诊断的个体(<0.001)。最后,南非的个体报告的应激、焦虑和抑郁水平高于其他国家(<0.01)。
在国际上,患有先前存在的和大流行后出现的失眠症状的个体在 COVID-19 大流行期间可能更容易受到应激、焦虑和抑郁的影响。公共卫生倡议应包括失眠症管理,以改善大流行期间的心理健康。